| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Revenue | 224,501 | 217,086 | 201,317 | 203,191 |
| Cost of goods sold | 31,773 | 34,672 | 30,709 | 32,398 |
| Gross profit | 192,728 | 182,414 | 170,608 | 170,793 |
| Selling, general and administrative | - | - | - | 130,392 |
| Research and development | 24,211 | 26,209 | 27,803 | 26,083 |
| Selling, general and administrative | 158,873 | 159,521 | 144,290 | - |
| Total operating expenses | 183,084 | 185,730 | 172,093 | 156,475 |
| Operating income | 9,644 | -3,316 | -1,485 | 14,318 |
| Interest and dividend income | 3,984 | 4,486 | 5,066 | 5,890 |
| Interest expense | 11 | 4 | - | - |
| Other expense (income), net | -66 | -3,498 | 578 | 118 |
| Total other income | 3,907 | 984 | 5,644 | 6,008 |
| Income before income taxes | 13,551 | -2,332 | 4,159 | 20,326 |
| Income taxes | 3,619 | 1,260 | 1,167 | 1,829 |
| Net income | 9,932 | -3,592 | 2,992 | 18,497 |
| Foreign currency translation (loss) gain | -59 | 191 | -300 | 259 |
| Unrealized gain on investments | 302 | -22 | -9 | 1,556 |
| Total comprehensive income | 10,175 | -3,423 | 2,683 | 20,312 |
| Basic (in dollars per share) | 0.34 | -0.12 | 0.1 | 0.62 |
| Basic (in shares) | 29,332,376 | 29,506,807 | 29,702,358 | 29,879,621 |
| Diluted (in dollars per share) | 0.34 | -0.12 | 0.1 | 0.6 |
| Diluted (in shares) | 29,600,223 | 29,506,807 | 30,311,476 | 30,633,789 |
Inspire Medical Systems, Inc. (INSP)
Inspire Medical Systems, Inc. (INSP)